Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CapsoVision, Inc Director's Dealing 2025

Jul 7, 2025

33655_dirs_2025-07-07_953acada-9952-4fc5-af5c-39740fe24cfe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CapsoVision, Inc (CV)
CIK: 0001378325
Period of Report: 2025-07-03

Reporting Person: Tsai Chen Lung (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-03 Common Stock C 91432 Acquired 115456 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-07-03 Series B Preferred Stock $ C 71429 Disposed Common Stock (21450) Indirect
2025-07-03 Series D-1 Preferred Stock $ C 55555 Disposed Common Stock (16683) Indirect
2025-07-03 Series E Preferred Stock $ C 86956 Disposed Common Stock (26112) Indirect
2025-07-03 Series H Preferred Stock $ C 90534 Disposed Common Stock (27187) Indirect

Footnotes

F1: Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.

F2: The securities are held by The Tsai Family Trust, for which the Reporting Person, together with his wife, are trustees.